Trial intelligence / Profile preview

PLAUDIT: Ezetimibe and Simvastatin on Platelet Function in Diabetes

NCT01035320Phase 4Completed

Sponsor
Karolinska Institutet
Start
Jan 2006
Primary completion
Jun 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ezetimibe in hypercholesterolemia, sponsored by Karolinska Institutet. Primary endpoint: Thrombogenic mechanisms. Started Jan 2006; status: completed.

02

Drugs

ezetimibe
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT01035320.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01035320.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call